{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T12:12:34Z","timestamp":1694088754280},"reference-count":46,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2021.2469","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T12:29:54Z","timestamp":1639657794000},"source":"Crossref","is-referenced-by-count":2,"title":["Overexpression of the PPAR\u2011\u03b3 protein in primary Ta\/T1 non\u2011muscle\u2011invasive urothelial carcinoma"],"prefix":"10.3892","volume":"16","author":[{"given":"Shinichi","family":"Tanaka","sequence":"first","affiliation":[{"name":"Laboratory of Pathology, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Kagawa 761\u20110123, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Tokuhara","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Kagawa 761\u20110123, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Ehime Prefectural University of Health Sciences, Iyo, Ehime 791\u20112101, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ohsaki","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Department of Medical Technology, Kobe University Graduate School of Health Sciences, Kobe, Hyogo\u00a0654\u20110142, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Morinishi","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Kagawa 761\u20110123, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shikoku Cancer Center, Matsuyama, Ehime 791\u20110280, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shikoku Cancer Center, Matsuyama, Ehime 791\u20110280, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Kagawa 761\u20110123, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"key20220302121557_b1-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: A global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"key20220302121557_b2-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: A comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur Urol"},{"key":"key20220302121557_b3-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: Prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"key20220302121557_b4-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"key20220302121557_b5-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"key":"key20220302121557_b6-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/2030","article-title":"Differentiation and reversal of malignant changes in colon cancer through PPARgamma","volume":"4","author":"Sarraf","year":"1998","journal-title":"Nat Med"},{"key":"key20220302121557_b7-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10620-007-9794-4","article-title":"Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: Correlation with histopathological parameters, cell cycle-related molecules, and patients' survival","volume":"52","author":"Theocharis","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"e58749","key":"key20220302121557_b8-MCO-16-2-02469","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058749","article-title":"PTB-associated splicing factor (PSF) is a PPAR\u03b3-binding protein and growth regulator of colon cancer cells","volume":"8","author":"Tsukahara","year":"2013","journal-title":"PLoS One"},{"issue":"204","key":"key20220302121557_b9-MCO-16-2-02469","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5426-6","article-title":"PPAR\u03b3 activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway","volume":"19","author":"Lv","year":"2019","journal-title":"BMC Cancer"},{"key":"key20220302121557_b10-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/em.22345","article-title":"4-nitrophenol exposure in T24 human bladder cancer cells promotes proliferation, motilities, and epithelial-to-mesenchymal transition","volume":"61","author":"Dong","year":"2020","journal-title":"Environ Mol Mutagen"},{"key":"key20220302121557_b11-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/sj.bjc.6602244","article-title":"Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma","volume":"92","author":"Zhang","year":"2005","journal-title":"Br J Cancer"},{"key":"key20220302121557_b12-MCO-16-2-02469","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"key20220302121557_b13-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.prp.2017.04.009","article-title":"Diagnostic utility of Ki-67 immunohistochemistry in small endoscopic biopsies of the ureter and renal pelvis","volume":"213","author":"Koyama","year":"2017","journal-title":"Pathol Res Pract"},{"key":"key20220302121557_b14-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.juro.2013.07.012","article-title":"Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma","volume":"191","author":"Krabbe","year":"2014","journal-title":"J Urol"},{"key":"key20220302121557_b15-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"key20220302121557_b16-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"key20220302121557_b17-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"key20220302121557_b18-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"key20220302121557_b19-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","article-title":"Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines","volume":"6","author":"Ellrott","year":"2018","journal-title":"Cell Syst"},{"key":"key20220302121557_b20-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","article-title":"Genomic and functional approaches to understanding cancer aneuploidy","volume":"33","author":"Taylor","year":"2018","journal-title":"Cancer Cell"},{"key":"key20220302121557_b21-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA Pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"key20220302121557_b22-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"key20220302121557_b23-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep"},{"key":"key20220302121557_b24-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","article-title":"Microbiome analyses of blood and tissues suggest cancer diagnostic approach","volume":"579","author":"Poore","year":"2020","journal-title":"Nature"},{"key":"key20220302121557_b25-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cell.2018.03.033","article-title":"Perspective on oncogenic processes at the end of the beginning of cancer genomics","volume":"173","author":"Ding","year":"2018","journal-title":"Cell"},{"key":"key20220302121557_b26-MCO-16-2-02469","author":"Bonneville"},{"key":"key20220302121557_b27-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.anndiagpath.2017.11.007","article-title":"Peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer","volume":"33","author":"Yun","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"key20220302121557_b28-MCO-16-2-02469","first-page":"733","article-title":"Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells","volume":"11","author":"Michael","year":"2003","journal-title":"Int J Mol Med"},{"key":"key20220302121557_b29-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1006\/bbrc.2000.2436","article-title":"Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis","volume":"270","author":"Tsubouchi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220302121557_b30-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.134.1.13","article-title":"Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis","volume":"134","author":"Grimm","year":"1996","journal-title":"J Cell Biol"},{"key":"key20220302121557_b31-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/s0024-3205(02)01510-2","article-title":"Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer","volume":"70","author":"Chen","year":"2002","journal-title":"Life Sci"},{"key":"key20220302121557_b32-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/sj.onc.1204926","article-title":"Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer","volume":"20","author":"Catz","year":"2001","journal-title":"Oncogene"},{"key":"key20220302121557_b33-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/s0002-9440(10)61730-0","article-title":"Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells","volume":"159","author":"Nakashiro","year":"2001","journal-title":"Am J Pathol"},{"issue":"35783","key":"key20220302121557_b34-MCO-16-2-02469","doi-asserted-by":"publisher","DOI":"10.1038\/srep35783","article-title":"Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPAR\u03b3 signalling pathway","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"key20220302121557_b35-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.urolonc.2009.04.019","article-title":"Molecular pathways of urothelial development and bladder tumorigenesis","volume":"28","author":"Castillo-Martin","year":"2010","journal-title":"Urol Oncol"},{"key":"key20220302121557_b36-MCO-16-2-02469","first-page":"784","article-title":"Two molecular pathways to transitional cell carcinoma of the bladder","volume":"54","author":"Spruck","year":"1994","journal-title":"Cancer Res"},{"key":"key20220302121557_b37-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejso.2008.04.003","article-title":"Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: Association with differentiation, proliferation and clinical outcome","volume":"35","author":"Mylona","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"key20220302121557_b38-MCO-16-2-02469","first-page":"1458","article-title":"Urothelial eddies in papillary urothelial neoplasms: A distinct morphologic pattern with low risk for progression","volume":"6","author":"Kim","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"key20220302121557_b39-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00428-008-0585-x","article-title":"Diagnostic algorithm for papillary urothelial tumors in the urinary bladder","volume":"452","author":"Shim","year":"2008","journal-title":"Virchows Arch"},{"key":"key20220302121557_b40-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.21873\/anticanres.12685","article-title":"Alterations of p53 and Rb pathways are associated with high proliferation in bladder urothelial carcinomas","volume":"38","author":"Goussia","year":"2018","journal-title":"Anticancer Res"},{"key":"key20220302121557_b41-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/jcp.2004.022939","article-title":"Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder","volume":"59","author":"Quintero","year":"2006","journal-title":"J Clin Pathol"},{"key":"key20220302121557_b42-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1590\/s0100-69912012000500010","article-title":"Superficial papillary urothelial neoplasms of the bladder (PTA E PT1): Correlation of expression of P53, KI-67 and CK20 with histologic grade, recurrence and tumor progression","volume":"39","author":"Ogata","year":"2012","journal-title":"Rev Col Bras Cir"},{"key":"key20220302121557_b43-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1440-1827.2011.02694.x","article-title":"Association between the expression pattern of p16, pRb and p53 and the response to intravesical bacillus Calmette-Guerin therapy in patients with urothelial carcinoma in situ of the urinary bladder","volume":"61","author":"Sato","year":"2011","journal-title":"Pathol Int"},{"key":"key20220302121557_b44-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1464-410x.1988.tb04296.x","article-title":"Diagnostic efficacy of the combination of urine cytology, urine analysis and history in the follow-up of bladder carcinoma","volume":"62","author":"Meuleman","year":"1988","journal-title":"Br J Urol"},{"key":"key20220302121557_b45-MCO-16-2-02469","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0022-5347(01)63184-7","article-title":"Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?","volume":"159","author":"Wiener","year":"1998","journal-title":"J Urol"},{"key":"key20220302121557_b46-MCO-16-2-02469","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jasc.2016.02.004","article-title":"Voided urine cytology and low-grade urothelial neoplasia of the bladder: Factors that influence the sensitivity","volume":"5","author":"Yamashiro","year":"2016","journal-title":"J Am Soc Cytopathol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:19:23Z","timestamp":1646216363000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2021.2469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,16]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2021.2469","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"article-number":"36"}}